Published in Eur J Cancer on January 01, 1980
Screening for psychiatric morbidity in patients with advanced breast cancer: validation of two self-report questionnaires. Br J Cancer (1991) 1.83
Psychological impact of adjuvant chemotherapy in the first two years after mastectomy. Br Med J (Clin Res Ed) (1986) 1.51
Chemotherapy of advanced breast cancer: outcome and prognostic factors. Br J Cancer (1993) 1.45
New treatments for advanced cancer: an approach to prioritization. Br J Cancer (2000) 1.41
Psychiatric morbidity in patients with advanced cancer of the breast: prevalence measured by two self-rating questionnaires. Br J Cancer (1991) 1.21
Do patients with advanced breast cancer benefit from chemotherapy? Br J Cancer (1998) 1.01
Quality of life after cytotoxic chemotherapy: discussion paper. J R Soc Med (1984) 0.90
Breast cancer (metastatic). BMJ Clin Evid (2007) 0.82
Response to treatment of breast cancer. Breast Cancer Res Treat (1991) 0.82
A daily diary for quality of life measurement in advanced breast cancer trials. Br J Cancer (1993) 0.82
Endocrine symptom assessment in women with breast cancer: what a simple "yes" means. Support Care Cancer (2007) 0.81
Combination or mild single agent chemotherapy for advanced breast cancer? CMF vs epirubicin measuring quality of life. Br J Cancer (1993) 0.80
Breast cancer (metastatic). BMJ Clin Evid (2010) 0.77
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet (2005) 11.05
Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial. BMJ (1990) 10.93
First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial. Lancet (2002) 6.02
Effects of breast conservation on psychological morbidity associated with diagnosis and treatment of early breast cancer. Br Med J (Clin Res Ed) (1986) 5.37
Evaluation of quality of life in patients receiving treatment for advanced breast cancer. Lancet (1976) 4.53
Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol (1994) 4.50
Availability of cadaveric kidneys for transplantation. Br Med J (1971) 4.41
Cost-benefit analysis of long-term haemodialysis for chronic renal failure. Br Med J (1975) 3.87
Mortality from ischaemic heart disease--inter-town variation and its association with climate in England and Wales. Int J Epidemiol (1976) 3.57
Randomised controlled trial of antibiotics in patients with cough and purulent sputum. Br Med J (1976) 3.57
Psychological effects of being offered choice of surgery for breast cancer. BMJ (1994) 3.48
Psychological rehabilitation after myocardial infarction: multicentre randomised controlled trial. BMJ (1996) 3.05
Do we need informed consent? Lancet (1986) 3.02
Shortening waiting lists in orthopaedic surgery outpatient clinics. Br Med J (Clin Res Ed) (1982) 2.87
Can magnetic-resonance imaging help elucidate natural history of breast cancer multicentricity? Lancet (1998) 2.70
Breast cancer, desmoid tumours, and familial adenomatous polyposis--a unifying hypothesis. Lancet (1993) 2.69
Primary management of carcinoma of the breast. Lancet (1993) 2.59
Screening for breast cancer, time to think--and stop? Lancet (1995) 2.58
A cytoplasmic dynein heavy chain is required for oscillatory nuclear movement of meiotic prophase and efficient meiotic recombination in fission yeast. J Cell Biol (1999) 2.48
Accuracy of cancer registration. Br J Prev Soc Med (1976) 2.44
The spindle pole body of Schizosaccharomyces pombe enters and leaves the nuclear envelope as the cell cycle proceeds. Mol Biol Cell (1997) 2.41
Structural organization and functional analysis of centromeric DNA in the fission yeast Schizosaccharomyces pombe. Mol Cell Biol (1988) 2.37
Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat Rep (1987) 2.37
Clinical syndromes of mastalgia. Lancet (1976) 2.35
Mass screening for cancer of the breast. Lancet (1968) 2.33
Screening for anxiety and depression in cancer patients: the effects of disease and treatment. Eur J Cancer (1994) 2.26
Is clinical breast examination an acceptable alternative to mammographic screening? BMJ (2000) 2.18
Oestrogen as a reticuloendothelial stimulant in patients with cancer. Br Med J (1971) 2.14
Can results from clinical trials be generalized? Nat Med (1995) 2.13
Regional variations in need for and provision and use of child health services in England and Wales. Br Med J (1976) 2.06
Time to abandon TNM staging of breast cancer? Lancet (1992) 2.05
Clinical judgment in the diagnosis and management of frequency and dysuria in general practice. Br Med J (Clin Res Ed) (1984) 1.93
Epidemiological aspects of the 1969 yellow fever epidemic in Nigeria. Bull World Health Organ (1972) 1.86
Human herpesvirus type 8 DNA sequences in cell-free plasma and mononuclear cells of Kaposi's sarcoma patients. J Infect Dis (1996) 1.85
Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status. Ann Oncol (2006) 1.85
What are the psychological factors influencing attendance, non-attendance and re-attendance at a breast screening centre? J R Soc Med (1990) 1.83
A new biological framework for cancer research. Lancet (1996) 1.73
Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: presence of tumor necrosis factor-alpha+ cells and dominance of granzyme A+, CD8+ lymphocytes. Am J Trop Med Hyg (1993) 1.73
Changes over time in socioeconomic inequalities in breast and rectal cancer survival in England and Wales during a 32-year period (1973-2004): the potential role of health care. Ann Oncol (2011) 1.72
Contribution of Gardnerella vaginalis to vaginitis in a general practice. Br Med J (Clin Res Ed) (1986) 1.72
Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment. Cancer Res (1992) 1.71
Organization of clinical trial on national scale: management of early cancer of the breast. Br Med J (1972) 1.70
Reticulo-endothelial activity in humans with cancer. Br J Surg (1970) 1.69
Improved survival among patients treated with adjuvant tamoxifen after mastectomy for early breast cancer. Lancet (1983) 1.61
Do psychological studies upset patients? J R Soc Med (1987) 1.60
Should lymphadenectomy be discarded? I. Immunological considerations. J R Coll Surg Edinb (1973) 1.60
The effects of surgery on tumor growth: a century of investigations. Ann Oncol (2008) 1.59
Postoperative radiotherapy and late mortality: evidence from the Cancer Research Campaign trial for early breast cancer. BMJ (1989) 1.59
Apical extracellular calcium/polyvalent cation-sensing receptor regulates vasopressin-elicited water permeability in rat kidney inner medullary collecting duct. J Clin Invest (1997) 1.59
Effect of mithramycin on calcium and hydroxyproline metabolism in patients with malignant disease. Br Med J (1967) 1.58
Effect of prenatal dexamethasone on rat renal development. Kidney Int (2001) 1.58
Contralateral renal abnormalities in multicystic-dysplastic kidney disease. J Pediatr (1992) 1.57
Putting the risk of breast cancer in perspective. BMJ (1998) 1.56
High death rates: more deaths or earlier deaths? J R Coll Physicians Lond (1987) 1.56
Median sternotomy wound dehiscence: a retrospective case control study of risk factors and outcome. J R Coll Surg Edinb (1992) 1.56
Comparative trial of endocrine versus cytotoxic treatment in advanced breast cancer. Br Med J (1977) 1.55
Tamoxifen and contralateral breast cancer. Lancet (1985) 1.53
False positive findings of mammography will have psychological consequences. BMJ (1996) 1.51
Does surgery disseminate or accelerate cancer? Lancet (1996) 1.50
pkl1(+)and klp2(+): Two kinesins of the Kar3 subfamily in fission yeast perform different functions in both mitosis and meiosis. Mol Biol Cell (2001) 1.50
Importance of mastalgia in operable breast cancer. Br Med J (Clin Res Ed) (1982) 1.49
The trials of Dr. Bernard Fisher: a European perspective on an American episode. Control Clin Trials (1997) 1.49
Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts. Br J Cancer (1990) 1.48
The hypronosticon test in breast cancer. Clin Oncol (1975) 1.47
Clinical decision-making: coping with uncertainty. Postgrad Med J (2002) 1.47
Geographical variation mortality from ischaemic heart disease in England and Wales. Br J Prev Soc Med (1977) 1.46
Addressing the psychological needs of the conservatively treated breast cancer patient: discussion paper. J R Soc Med (1987) 1.46
Rationalism versus irrationalism in the care of the sick: science versus the absurd. Med J Aust (1990) 1.46
Variations in gastric cancer mortality in South Wales. Clin Oncol (1979) 1.45
Loss of skeletal calcium by patients on maintenance dialysis. Br Med J (1970) 1.42
Dormancy and surgery-driven escape from dormancy help explain some clinical features of breast cancer. APMIS (2008) 1.42
A mathematical model of an integrated haemodialysis and renal transplantation programme. Br J Prev Soc Med (1974) 1.41
Cognition and immune function in HIV-1 infection. AIDS (1992) 1.41
Further study into obstructive jaundice and ischaemic renal damage. Br Med J (1969) 1.41
Provision, uptake and cost of cardiac rehabilitation programmes: improving services to under-represented groups. Health Technol Assess (2004) 1.41
Placental metastases from bronchial carcinoma. Br Med J (1969) 1.40
Targeted intra-operative radiotherapy (Targit): an innovative method of treatment for early breast cancer. Ann Oncol (2001) 1.39
Management of early carcinoma of the breast. Lancet (1972) 1.38
Breast cancer screening for younger women is not an efficient use of resources. BMJ (1997) 1.38
Evaluation of radiography and isotopic scintigraphy for detecting skeletal metastases in breast cancer. Lancet (1976) 1.38
Scientific empiricism and clinical medicine: a discussion paper. J R Soc Med (1981) 1.37
Replication of centromere II of Schizosaccharomyces pombe. Mol Cell Biol (1995) 1.35
Urethral syndrome: a self limiting illness. Br Med J (Clin Res Ed) (1984) 1.33
Evidence for neutral transcellular NaCl transport and neutral basolateral chloride exit in the rabbit proximal convoluted tubule. J Clin Invest (1984) 1.32
Secondary prevention of non-fatal deliberate self-harm. The green card study. Br J Psychiatry (1993) 1.32
Insulin stimulates volume absorption in the rabbit proximal convoluted tubule. J Clin Invest (1987) 1.32
High mutation rate and mutational bias at (TAA)n microsatellite loci in chickpea (Cicer arietinum L.). Mol Genet Genomics (2001) 1.32
Benign breast disease: the cost of the service and the cost to the patient. World J Surg (1990) 1.31
Cloning of rat and mouse P2Y purinoceptors. Biochem Biophys Res Commun (1995) 1.30
'Should a mammographic screening programme carry the warning: screening can damage your health!'? Br J Cancer (1999) 1.30
Structure and function of Schizosaccharomyces pombe centromeres. Cold Spring Harb Symp Quant Biol (1993) 1.30
Breast cancer in elderly women: a Cancer Research Campaign trial comparing treatment with tamoxifen and optimal surgery with tamoxifen alone. The Elderly Breast Cancer Working Party. Br J Surg (1991) 1.29
The 'tru-cut' biopsy in breast cancer. Clin Oncol (1975) 1.29
Adjuvant treatment with tamoxifen. Side effects may have been overstated. BMJ (1996) 1.29
Counterregulation during hypoglycemia is directed by widespread brain regions. Diabetes (1993) 1.28
The operative management of subclinical breast cancer. Clin Oncol (1977) 1.27
Postoperative seroma following mastectomy and axillary dissection. Br J Surg (1987) 1.26